Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.In my previous Quest Diagnostics (NYSE: DGX ) article , I analyzed the company’s Q2 2024 earnings report, which produced a beat on EPS and revenue. The company did report that their base business revenue grew almostHe is the leader of the investing group ...